dot

 

 

 

 

____Home | Ask George | Educational Modules

dot

dot

Anticoagulant Therapy

Intravenous Lovenox and PTT

> Monday, November-12-2007
Dana Haas at St. Luke's Episcopal Hospital in Houston, TX asks about the effect of Lovenox on the ACT and PTT...
Full Story

The Effect of Argatroban on Factor Assays

> Monday, November-05-2007
On September 22 I received an e-mail question from "JLile" asking if Argatroban affects the outcomes of coagulation factor assays.
Full Story

What is a critical INR?

> Friday, November-02-2007

Anticoagulation Forum and CYP2C9

> Tuesday, October-30-2007

Kim Kinney's response about monitoring for CYP2C9 polymorphisms reminded me of last summer's Anticoagulation Forum exchange between...

Full Story

More on the INR

> Monday, October-15-2007

I routinely monitor Pat Letendre's bulletin board service, Medlab-L, and lately there has been a thread discussing whether to report the INR alone or with the prothrombin time. Here is a comment from Dave McGlasson that I found to be helpful.

Full Story

Genomic Screening for Warfarin Therapy

> Monday, October-08-2007

Last Tuesday I attended a School of Public Health doctoral dissertation defense at the University of Alabama at Birmingham on the subject of testing CYP2C9 and VKORC1 polymorphisms...

Full Story

Should We Add AT To The Mix?

> Tuesday, October-02-2007

From Bob Gosselin at UC Davis: What is truth? Do we supplement with antithrombin (AT)...

Full Story

The INR, Again

> Monday, July-16-2007

Is the INR reliable?

Full Story

How Do You Monitor Arixtra?

> Thursday, July-12-2007
We’ve grown accustomed to using the chromogenic anti-Xa heparin assay to monitor unfractionated (standard) heparin...
Full Story

dot
dot dot
dot dot dot